Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 12 (H3P12) is annotated as a human pseudogene in the histone H3 family[4]. Histone H3 is a core nucleosomal protein involved in structuring chromatin and regulating gene expression through posttranslational modifications[1][2][3]. However, H3P12 itself is not a functional protein-coding gene; pseudogenes, by definition, are generally non-functional DNA segments that resemble a real gene but typically lack the regulatory elements or coding capability to produce an active protein[3][4]. There is no evidence that H3P12 has a physiological or pathological function, nor is it established as a therapeutic target, biomarker, or receptor. Additionally, there are no known interacting drugs, mechanisms of action, or safety concerns linked to this pseudogene. The broader histone H3 family plays a significant role in chromatin structure and gene regulation, but functional and disease associations pertain to the protein-coding H3 genes (such as H3.1, H3.2, and the variant H3.3) and not to H3 pseudogenes[1][2][3]. Pseudogenes such as H3P12 may exist in the genome without contributing to gene expression or protein function, and are often annotated during genomic studies of the histone H3 cluster[3][4]. Key points: - H3P12 does not code for a functional histone H3 protein. - There are no known biological or therapeutic roles for H3P12. - It is not a drug target, biomarker, or associated with other areas of molecular medicine. If your interest is in functional histone H3 proteins or variants (e.g., H3.3, encoded by H3F3A/B), these are distinct from pseudogenes and are actively involved in chromatin biology[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 12 (H3P12).